Following this suggestion, we have included in the analysis a calculation according to the FiO2. This has a cut-off which correlates to the oxygen flow cut-off.
The proposed timing of Tocilizumab administration based on oxygen flow rate is interesting but undoubtedly requires a more detailed statistical analysis to convince the readers.